03/07/2025
11:58 AM | JANUS HENDERSON GROUP PLC (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
03/05/2025
7:07 AM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2025
7:16 AM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2025
5:40 PM | Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
5:24 PM | CITADEL ADVISORS LLC (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025
10:23 AM | JANUS HENDERSON GROUP PLC (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/14/2025
5:31 AM | Opaleye Management Inc. (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/12/2025
8:30 AM | Adage Capital Management, L.P. (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
| Form SCHEDULE 13G | |
01/23/2025
3:05 PM | Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Zummo Jacqueline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:05 PM | Fry Hannah (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:05 PM | Fabbio Patrick (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for TARA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Protara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
01/23/2025
3:05 PM | Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Shefferman Jesse (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
3:34 PM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
3:20 PM | Fry Hannah (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
3:20 PM | Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Zummo Jacqueline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
3:20 PM | Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Shefferman Jesse (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
3:02 PM | Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
Velan Capital Investment Management LP (Filed by)
| Form SC 13G | |
12/11/2024
3:19 PM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2024
6:30 AM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 424B5 | |
12/09/2024
3:17 PM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 424B5 | |
12/05/2024
7:45 AM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
5:01 AM | Opaleye Management Inc. (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
| Form SC 13G | |
11/14/2024
11:19 AM | CVI Investments, Inc. (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
| Form SC 13G/A | |
09/12/2024
7:20 PM | Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
6:11 PM | Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
3:05 PM | Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Shefferman Jesse (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:16 PM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/18/2024
3:05 PM | Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
6:56 PM | Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
1:00 PM | Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
5:45 PM | Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
5:00 PM | BESHAR LUKE M (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
5:00 PM | GARCEAU ROGER (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
5:00 PM | Huang Jane (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
5:00 PM | Levy Richard S (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
5:00 PM | Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
SARGEN GREGORY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
5:00 PM | Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Solomon Michael Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
5:00 PM | Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Smith Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
5:00 PM | Flannelly Barry P (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
6:01 PM | Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
6:48 PM | Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Please don’t die on me (Ad) "Please don’t die on me," the nurse begged as Porter Stansberry lay in a hospital bed, his heart stopped from years of pushing himself too hard. At his lowest point, he realized that everything had gone wrong, and he was forced to rebuild—not just his health, but his entire life and fortune.
After clawing his way out of that abyss, Porter discovered a life-changing investment strategy, one that allowed him to rebuild his wealth far faster and with less risk than he ever imagined. This approach helped him earn enormous returns outside of the volatile stock market, and now he’s sharing it with you. While most won’t believe it’s possible, Porter is asking you to open your mind and consider a new way of investing—one that could transform your financial future, just as it did for him. [Click here] to learn more about this powerful strategy and discover your own financial "Second Life |
05/10/2024
5:57 PM | Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
11:15 PM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form EFFECT | |
05/02/2024
3:16 PM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/02/2024
7:05 AM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
7:10 AM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024
7:43 PM | Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
04/09/2024
9:43 AM | CVI Investments, Inc. (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
| Form SC 13G | |
04/05/2024
7:14 AM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
4:17 PM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
7:05 AM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
7:10 AM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
